Skip to content

To evaluate the effectiveness of Haridradi lepa in management of Mukhdushika (Acne vulgaris)

A Single Arm Clinical Study to Evaluate The Efficacy of Haridradi lepa in Management of Mukhdushika (Acne vulgaris) - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067018
Enrollment
35
Registered
2024-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Dr Priyanka Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of mukhdushika Age between 13 years to 50 years

Exclusion criteria

Exclusion criteria: Patients having known case of Eczema , Urticaria, Impetigo, Contact Dermatitis

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Haridradi lepa in reduction of mukhdushika using CASS ScaleTimepoint: 07 days

Secondary

MeasureTime frame
To assess the efficacy of Haridradi lepa in reduction of vedana(pain), vivarnta(discolouration), number of pidika by using subjective parameters.Timepoint: 07 days

Countries

India

Contacts

Public ContactDr Vaishali R Chaudhari

Dr.D.Y.Patil College of Ayurved and Research center,Pimpri,Pune.

vaishalidhandes@gmail.com9822964710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026